6 Meridian’s Quest Diagnostics DGX Stock Holding History

6 Meridian’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,680	Closed	-$222K	–	423
2021 Q2	$222K	Sell	1,680 -58	-3%	-$7.59K	0.02%	314
2021 Q1	$223K	Buy	+1,738	New	+$214K	0.02%	299

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

6 Meridian's DGX Position: Q3 2021 in Review

6 Meridian sold out of Quest Diagnostics (DGX) in Q3 2021, closing a stake of 1,680 shares — an estimated $222K sold.

6 Meridian first reported a position in DGX in Q1 2021 and held it in 2 quarters. The position peaked at $223K in Q1 2021. 838 funds tracked by Wall St. Rank hold DGX as of Q3 2021.

6 Meridian reported no remaining Quest Diagnostics position as of Q3 2021 after selling out during the quarter.
6 Meridian sold 1,680 Quest Diagnostics shares in Q3 2021, an estimated $222K.
6 Meridian first reported a position in Quest Diagnostics in Q1 2021 and held it in 2 quarters.
6 Meridian's Quest Diagnostics position peaked at $223K in Q1 2021.
838 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2021.

Based on 6 Meridian's 13F filing for Q3 2021, filed 3 Nov 2021.